0597-0585 : Adalimumab-adbmAdalimumab-adbm Kit
NDC: | 0597-0585 |
Labeler: | Boehringer Ingelheim Pharmaceuticals, Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | Adalimumab-adbm |
Dosage Form: | Kit |
Application #: | BLA761058 |
Rev. Date: |
NDC Package Codes:
- 0597-0585-89: 2 KIT IN 1 CARTON (0597‑0585‑89) / 1 KIT IN 1 KIT * 1 SYRINGE IN 1 TRAY (0597‑0580‑37) / .2 ML IN 1 SYRINGE * 1 ML IN 1 PACKET
Related Products:
Based on records with the same trade name.- 0597-0545 Adalimumab-adbmAdalimumab-adbm Kit by Boehringer Ingelheim Pharmaceuticals, Inc.
- 0597-0555 Adalimumab-adbmAdalimumab-adbm Kit by Boehringer Ingelheim Pharmaceuticals, Inc.
- 0597-0565 Adalimumab-adbmAdalimumab-adbm Kit by Boehringer Ingelheim Pharmaceuticals, Inc.
- 0597-0575 Adalimumab-adbmAdalimumab-adbm Kit by Boehringer Ingelheim Pharmaceuticals, Inc.
- 0597-0595 Adalimumab-adbmAdalimumab-adbm Kit by Boehringer Ingelheim Pharmaceuticals, Inc.
- 82009-144 Adalimumab-adbmAdalimumab-adbm Kit by Quallent Pharmaceuticals Health LLC
- 82009-146 Adalimumab-adbmAdalimumab-adbm Kit by Quallent Pharmaceuticals Health LLC
- 82009-148 Adalimumab-adbmAdalimumab-adbm Kit by Quallent Pharmaceuticals Health LLC
- 82009-150 Adalimumab-adbmAdalimumab-adbm Kit by Quallent Pharmaceuticals Health LLC
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 0597-0575Next: 0597-0595 >
Related Discussions:
Humira (adalimumab) for pain
I’m on Humira (adalimumab) for RA joint pain and would like to know how other people are doing on it? I’m do... 2 replies
I’m on Humira (adalimumab) for RA joint pain and would like to know how other people are doing on it? I’m do... 2 replies
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.